WebDisclosure WebDisclosure
Basculer en Français
9904 Companies
199530 Keywords
130380 Articles
106037 Press releases
Headlines Articles Press releases Gilero Remove
  1. Home
  2. Companies
  3. Gilero
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/21/2024 at 18:05, 1 year 8 months ago

    Gilero Recognized as a Winner in Triangle Business Journal's 2024 Life Sciences Awards

    Innovation Medical Devices Gilero Life Sciences Awards
  • BRIEF

    published on 05/21/2024 at 18:05, 1 year 8 months ago

    Gilero reconnu comme lauréat des Life Sciences Awards 2024 du Triangle Business Journal

    Innovation Équipement Médical Gilero Prix Des Sciences De La Vie
  • PRESS RELEASE

    published on 05/21/2024 at 18:00, 1 year 8 months ago

    Gilero Recognized as a Winner in Triangle Business Journal's 2024 Life Sciences Awards

    Gilero wins 'Best Early-Stage Product Development Company' award at Triangle Business Journal's 2024 Life Sciences Awards. CEO Ted Mosler expresses gratitude and highlights team's commitment to innovation
    Innovation Award Product Development Gilero Life Sciences Awards
    Logo of Gilero
Accesswire
  • Published on 02/20/2026 at 15:45, 2 hours 52 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

  • Published on 02/20/2026 at 14:30, 4 hours 7 minutes ago

    Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

  • Published on 02/20/2026 at 14:08, 4 hours 29 minutes ago

    Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange

  • Published on 02/20/2026 at 14:00, 4 hours 37 minutes ago

    Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

  • Published on 02/20/2026 at 13:30, 5 hours 7 minutes ago

    ESGold Launches 70 km2 District-Scale ANT Survey at Montauban Following 3D Model Identifying Deep, Expanding 2 km Mineralized Corridor

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 18:23, 14 minutes ago

    POS-Transaction in Own Shares

  • Published on 02/20/2026 at 18:00, 37 minutes ago

    Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme

  • Published on 02/20/2026 at 18:00, 37 minutes ago

    Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

  • Published on 02/20/2026 at 18:00, 37 minutes ago

    FLORENTAISE: Prolongation de la période d’observation Cession du site de Saint-Escobille

  • Published on 02/20/2026 at 17:50, 47 minutes ago

    Modigliani Leads Templum’s Major International Auction

View all EQS
Les Echos
  • Published on 02/20/2026 at 18:00, 37 minutes ago

    TERACT - Termination of liquidity agreement

  • Published on 02/20/2026 at 18:00, 37 minutes ago

    TERACT - Résiliation du contrat de liquidité

  • Published on 02/20/2026 at 17:35, 1 hour 2 minutes ago

    CHIFFRE D'AFFAIRES 2025

  • Published on 02/20/2026 at 09:28, 9 hours 9 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/20/2026 at 09:28, 9 hours 9 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy